Skip to content
Home/Companies/MedTech/Stago
Stago

Stago

MedTech·France·Active·New
Entry
2026
Hold
New
Status
Active

Who owns Stago?

Stago is a French MedTech company, currently owned by ARCHIMED since 2026.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
ARCHIMED
Investor
ARCHIMED
MED I · 2014 · Buyout

Key facts

SectorMedTech
StatusActive
Websitewww.stago.com

More from MED I

Other portfolio companies in the same fund.

Fytexia
4.0xExited 2023
HealthTechFrance· 2016
to Associated British Foods
Micromed
Micromed
Exited 2023
MedTechFrance· 2016
to Natus Medical (ARCHIMED portfolio company, intra-portfolio)
Natural Origins
Natural Origins
2.5xExited 2017
HealthTechFrance· 2016
to Dohler Group
Polyplus
Polyplus
300.0xExited 2023
BiotechFrance· 2016
to Sartorius Stedim
Deallus
Exited 2024
PharmaUK· 2015
to GlobalData Plc
Primo Group
Primo Group
3.0xExited 2024
HealthTechItaly· 2015
to Aksia

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Stago?

Stago is currently owned by ARCHIMED, through MED I, since 2026.

When did ARCHIMED acquire Stago?

ARCHIMED acquired Stago in 2026.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue